欢迎来到《四川大学学报(医学版)》
杨晋军, 陈心传, 唐韫等. 血管内大B细胞淋巴瘤17例临床分析[J]. 四川大学学报(医学版), 2018, 49(1): 145-147.
引用本文: 杨晋军, 陈心传, 唐韫等. 血管内大B细胞淋巴瘤17例临床分析[J]. 四川大学学报(医学版), 2018, 49(1): 145-147.
YANG Jin-jun, CHEN Xin-chuan, TANG Yun. et al. Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases[J]. Journal of Sichuan University (Medical Sciences), 2018, 49(1): 145-147.
Citation: YANG Jin-jun, CHEN Xin-chuan, TANG Yun. et al. Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases[J]. Journal of Sichuan University (Medical Sciences), 2018, 49(1): 145-147.

血管内大B细胞淋巴瘤17例临床分析

Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases

  • 摘要: 目的 分析血管内大B细胞淋巴瘤的临床特点、治疗及预后。方法 回顾性分析四川大学华西医院血液科2009年2月至2015年7月诊治的17例血管内大B细胞淋巴瘤患者的临床资料,并进行生存分析。结果 纳入患者17例,男10例,女7例,发病年龄24~83岁,平均53岁;反复发热是患者最常见的首发症状(76.5%),骨髓是最易累及的部位(64.7%),临床分期多为ⅣB期(70.6%),常合并噬血细胞综合征(29.4%)。R-CHOP(利妥昔单抗、环磷酰胺、表阿霉素、长春地辛、强的松)或CHOP方案化疗(10例)可以显著改善患者的生存时间(与未治疗的7例患者相比,P=0.000 2)。骨髓受累的患者治疗后易复发。结论 血管内大B细胞淋巴瘤侵袭性强,预后差。R-CHOP方案化疗可以显著改善患者的预后,治疗后获得完全缓解的患者进行自体造血干细胞移植,可能在长期生存上获益。

     

    Abstract: Objective To analyze the clinical features, response to therapy and prognosis of intravascular large B-cell lymphoma (IVLBCL). Methods The clinical data of 17 cases with IVLBCL were retrospectively reviewed, and survival analysis was conducted. Results The study involved 10 males and 7 females of IVLBCL with a mean age of 53 years old. The most common symptom of the disease was recurrent fever (76.5%). The lymphoma was mainly observed in bone marrow (64.7%) and was clinically determined as stage ⅣB (70.6%). Many of the patients were also diagnosed with the hemophagocytic syndrome (29.4%). R-CHOP (rituximab, cyclophosphamide, epirubicin, vindesine, prednisone) or CHOP regimen chemotherapy significantly improved the survival of the patients (P=0.000 2). Unfortunately, those patients with bone marrow involvement were prone to relapse after treatment. Conclusion IVLBCL is highly invasive and associated with poor prognosis. R-CHOP chemotherapy can significantly improve the prognosis.

     

/

返回文章
返回